Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jade Ghosn

Showing results (61-70 of 267) with videos related to

Pageof 27
Sort By:
Genome Medicine|July 3, 2026
Identification and functional characterization of regulatory variants in DPP9 associated with COVID-19 severityGaëlle Farah, Magali Torres, Leo Henches, et al.
The Journal of Antimicrobial Chemotherapy|July 20, 2016
HIV-1-RNA in seminal plasma correlates with detection of HIV-1-DNA in semen cells, but not with CMV shedding, among MSM on successful antiretroviral regimensPierre Gantner, Lambert Assoumou, Marianne Leruez-Ville, et al.
Clinical Microbiology Reviews|August 26, 2016
Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical ImplicationsVéronique Avettand-Fènoël, Laurent Hocqueloux, Jade Ghosn, et al.
Plos One|September 3, 2011
X4 tropic multi-drug resistant quasi-species detected at the time of primary HIV-1 infection remain exclusive or at least dominant far from PHIJade Ghosn, Julie Galimand, Stéphanie Raymond, et al.
AIDS (London, England)|September 15, 2004
MIV-310 reduces HIV viral load in patients failing multiple antiretroviral therapy: results from a 4-week phase II studyChristine Katlama, Jade Ghosn, Roland Tubiana, et al.
Plos One|February 9, 2021
Ambulatory anal self-sampling in MSM living with HIV, an acceptable and reliable screening methodBenoît Heid-Picard, Béatrix Cochand-Priollet, Flore Rozenberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 18, 2003
Atypical toxoplasmic manifestation after discontinuation of maintenance therapy in a human immunodeficiency virus type 1-infected patient with immune recoveryJade Ghosn, Luc Paris, Daniel Ajzenberg, et al.
Journal of Medical Virology|September 22, 2012
Lack of benefit of 3-month intensification with enfuvirtide plus optimized background regimen (OBR) versus OBR alone in patients with multiple therapeutic failures: the INNOVE studyLaurence Morand-Joubert, Jade Ghosn, Constance Delaugerre, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2014
Significant reduction in HIV virologic failure during a 15-year period in a setting with free healthcare accessConstance Delaugerre, Jade Ghosn, Jean-Marc Lacombe, et al.
Sexually Transmitted Infections|January 6, 2026
Oral and anal shedding of <i>Treponema pallidum</i> in patients with syphilis in the DOXYVAC cohortRomain Salle, Philippe Alain Grange, Moussa Ouattara, et al.
Pageof 27

Showing results (61-70 of 267) with videos related to

Sort By:
Pageof 27
Genome Medicine|July 3, 2026
Identification and functional characterization of regulatory variants in DPP9 associated with COVID-19 severityGaëlle Farah, Magali Torres, Leo Henches, et al.
The Journal of Antimicrobial Chemotherapy|July 20, 2016
HIV-1-RNA in seminal plasma correlates with detection of HIV-1-DNA in semen cells, but not with CMV shedding, among MSM on successful antiretroviral regimensPierre Gantner, Lambert Assoumou, Marianne Leruez-Ville, et al.
Clinical Microbiology Reviews|August 26, 2016
Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical ImplicationsVéronique Avettand-Fènoël, Laurent Hocqueloux, Jade Ghosn, et al.
Plos One|September 3, 2011
X4 tropic multi-drug resistant quasi-species detected at the time of primary HIV-1 infection remain exclusive or at least dominant far from PHIJade Ghosn, Julie Galimand, Stéphanie Raymond, et al.
AIDS (London, England)|September 15, 2004
MIV-310 reduces HIV viral load in patients failing multiple antiretroviral therapy: results from a 4-week phase II studyChristine Katlama, Jade Ghosn, Roland Tubiana, et al.
Plos One|February 9, 2021
Ambulatory anal self-sampling in MSM living with HIV, an acceptable and reliable screening methodBenoît Heid-Picard, Béatrix Cochand-Priollet, Flore Rozenberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 18, 2003
Atypical toxoplasmic manifestation after discontinuation of maintenance therapy in a human immunodeficiency virus type 1-infected patient with immune recoveryJade Ghosn, Luc Paris, Daniel Ajzenberg, et al.
Journal of Medical Virology|September 22, 2012
Lack of benefit of 3-month intensification with enfuvirtide plus optimized background regimen (OBR) versus OBR alone in patients with multiple therapeutic failures: the INNOVE studyLaurence Morand-Joubert, Jade Ghosn, Constance Delaugerre, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2014
Significant reduction in HIV virologic failure during a 15-year period in a setting with free healthcare accessConstance Delaugerre, Jade Ghosn, Jean-Marc Lacombe, et al.
Sexually Transmitted Infections|January 6, 2026
Oral and anal shedding of <i>Treponema pallidum</i> in patients with syphilis in the DOXYVAC cohortRomain Salle, Philippe Alain Grange, Moussa Ouattara, et al.
Pageof 27